AGEN stock surged roughly 100% Monday after securing $340 million in private financing for an immunotherapy combo targeting colorectal cancer. Investors should remember: early-stage biotech doubles happen fast and fall even faster.
Twin Vee PowerCats announced a merger Monday, triggering a classic low-float spike that faded fast. Heavy cash burn collides with solid balance-sheet liquidity.
The apparel retailer reported Q1 earnings more than triple analyst expectations, sending CTRN to the top of small-cap gainers. Here's what actually happened.
The tiny battery maker was added to a major index chasing AI data-center demand, but investors should remember: $25M market cap, $1M revenue.
Cuprina Holdings received FDA clearance for MEDIFLY Maggots, sending shares sharply higher on heavy volume. Here's what actually changed—and why penny-stock rallies like this demand caution.
DFTX closed an upsized capital raise following Phase 3 trial success, signaling investor backing for the speculative biotech play.
The budget apparel retailer led small-cap gainers today, but momentum in penny stocks can reverse just as fast. Here's what you need to know before chasing the move.